SCHEMBL17970544

SCHEMBL17970544

CC(C)n1ccc2c(C(=O)N=O)ccc(O)c21

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17970548 0.83 KDM4A (0.41) ALDH1A1
SCHEMBL17970371 0.72 EZH2 (0.35)
SCHEMBL17970532 0.71 KDM4E (0.41) ALDH1A1
SCHEMBL17970581 0.69 EZH2 (0.35) ALDH1A1
SCHEMBL17970366 0.69 EZH2 (0.35) ALDH1A1LMNAHTT
SCHEMBL17970530 0.67
SCHEMBL19903102 0.59 TUBB4A (0.50) ALDH1A1LMNAHTT
Hydrochloric Acid SCHEMBL7884826 0.59 EZH2 (0.43)
SCHEMBL19048549 0.58 KDM4E (0.50) ALDH1A1LMNA
SCHEMBL30500734 0.58 NOTUM (0.50) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2773754-B1 Compounds for use in the treatment of T-cell mediated diseases GLAXOSMITHKLINE IP NO 2 LTD (GB) 2016-08-03 EP disclosed